MiMedx Group Investor Relations Material

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. MiMedx's products comprise placenta tissue allografts, umbilical cord blood allografts, amniotic membranes and amniotic allografts. The Company’s placental tissue pacification system which is the world’s first non-hormonal device (Harmony), comprises a combination of devices that are temporarily implanted into a patient to help restore normal hormonal and endocrine levels in women who have undergone a hysterectomy or oophorectomy due to cancer. Other products sold by MiMedx include a range of tissue conditioners, skin substitutes and hyaluronic acid gel products.